Transport iron normally exists in the plasma as ferric beta-l-globulinate. Since in most individuals the greater part of the body iron is incorporated in the hemoglobin of the red blood cells, it is probable that changes in the production and destruction of these erythrocytes will be reflected in the turnover of plasma iron. Radioactive iron of high specific activity is particularly useful for a study of iron metabolism since it can be injected intravenously in tracer amounts without changing the steady state of the organism; the turnover of this radioiron will then mirror the metabolism of the iron in the body.
Transport iron normally exists in the plasma as ferric beta-l-globulinate. Since in most individuals the greater part of the body iron is incorporated in the hemoglobin of the red blood cells, it is probable that changes in the production and destruction of these erythrocytes will be reflected in the turnover of plasma iron. Radioactive iron of high specific activity is particularly useful for a study of iron metabolism since it can be injected intravenously in tracer amounts without changing the steady state of the organism; the turnover of this radioiron will then mirror the metabolism of the iron in the body.
Flexner, Vosburgh, and Cowie (1) demonstrated that shortly after the intravenous injection of radioiron into guinea pigs, all the tagged iron in the plasma was in combination with beta-l-globulin. Following the injection of small quantities of such labelled plasma into other guinea pigs, the circulating plasma radioiron level decreased exponentially for the duration of the experiment. Labelled ferric beta-l-globulinate was also produced in vitro by the above investigators by incubating radioactive ferric chloride with a small amount of plasma. However, the intravenous injection of this mixture into guinea pigs was followed by a rapid loss of the plasma radioiron for about 30 minutes, following which the decrease again became exponential. The early rapid loss was presumably due to incomplete combination of the iron with the beta-l-globulin of the plasma and the diffusion of part of the injected iron into the tissues.
Similar results in humans utilizing in vitro tagged plasma were reported by Huff, Hennessy and Lawrence (2) and Huff and associates (3) . Although in most instances, in vitro incubation of radioiron with patients' plasma resulted in a con- stant rate of disappearance of the radioactivity from the plasma following its injection intravenously, occasionally exponential disappearance rates were not obtained; the latter were thought to be due either to insufficient metal combining protein in the plasma or to the presence of an abnormal protein.
The following investigations of the plasma iron disappearance rate were undertaken to elucidate one phase of iron metabolism in anemic individuals in whom the anemia was due to bone marrow hypofunction; other patients with blood dyscrasias were also studied for comparison. A solution of plasma fraction IV-7 2 was utilized for incubation with the radioactive iron since it was found that patients' plasma was on the whole unsatisfactory, due to variations in the latent iron binding capacities of such plasmas (4 
RESULTS
The disappearance of the injected labelled ferric beta-l-globulinate from the circulating plasma was exponential in all cases for the period of time followed. On semilogarithmic paper a straight line plot could be obtained and the rate of decrease in radioactivity determined by the slope of the line. For purposes of this report, this rate is expressed in terms of the half-time of disappearance (T%), i.e., the time in minutes for the radioactivity of the plasma to be decreased to 50%o of its initial value.
Values for absolute plasma iron turnover per unit time may be calculated from the radioiron disappearance data and the total plasma iron (3). Our results agree in general with those of Huff and his coworkers; several factors may influence this absolute iron turnover and form the basis of another report.
Studies on eight normal adult individuals and 32 patients with various blood dyscrasias comprise this report. From the data obtained in the former group, the normal pattern of plasma iron disappearance was derived. No attempt was made to ascertain the influence of various subsidiary factors as age, weight, sex, metabolic rate, and -diet in essentially normal persons that could perhaps have some influence upon the plasma clearance data. These factors may require elucidation in the future. However, there is reason to believe that such variables will not have a decisive influence upon the results in the present study.
The results obtained are summarized in Table  I and Figures 1, 2 , and 3. The half-time of disappearance of the radioiron in the normals ranged from 70 to 140 minutes with an average of 90 minutes.
Three adult patients with chronic aplastic anemia (cases 9, 10, 11), in whom the diagnosis had been made on the basis of the usual clinical and laboratory data, were studied. Each had received 150 or more transfusions over a period of several years, and there was a uniform darkening of the skin and no splenomegaly. Skin biopsies revealed hemosiderosis. The serum iron was elevated and there was complete saturation of the beta-l-globulin. The disappearance of radioiron from the plasma was markedly prolonged with half-time values of 220, 260, and 270 minutes, respectively. A fourth patient (case 12) with a hypoplastic anemia and a superimposed hemolytic component who had received 15 transfusions totalling 7,500 ml. of blood, similarly showed a prolonged half-time of disappearance of 215 minutes. A few weeks following splenectomy, this value remained essentially unchanged at 225 minutes.
In addition, two patients, aged 10 and 22 years (cases 13 and 14) with a syndrome similar to aplastic anemia, namely, chronic aregenerative anemia, who had been transfused approximately bimonthly since birth were studied. They both showed a paucity of red cell precursors in the bone marrow, a severe normochromic anemia with normal white cells and platelets in the peripheral blood and the usual evidence of widespread hemosiderosis. The serum iron was elevated in both and the beta-l-globulin was completely saturated. The half-time of disappearance in both these cases was markedly prolonged to 205 and 245 minutes.
Another group of subjects showing bone mar- Shaded area is normal range with average T/ = 90 min. Note the very rapid half-times of disappearance in the presence of hyperactive erythropoiesis, and the markedly prolonged TM when red cell production is diminished or absent. latent binding capacities of the sera were zero. In the former case, the half-time of disappearance was 95 minutes while in the latter it was markedly prolonged to 210 minutes. This patient was the only member of the myelofibrosis group to have an abnormally prolonged T%. Subsequent postmortem examination revealed marked myeloid metaplasia of the spleen and widespread generalized hemosiderosis.
In 
DISCUSSION
In early experiments, the radioiron was incubated in titro with the patient's own plasma prior to its intravenous injection. Although this technique gave reliable results in many individuals, it was observed that in subjects with hemosiderosis, the radioactive iron was, lost from the plasma at a-very rapid rate. This was found to be due to the fact that the beta-l-globulin of the plasma of these patients was already saturated with iron, hence combination between the radioiron and the plasma globulin did not occur. The iron injected thus remained in the ionic form and its rate of disappearance from the blood stream was markedly different from that of iron bound to globulin (4) . The initial rapid loss of the tagged iron is probably due to diffusion into the intercellular space whereas the subsequent exponential disappearance of globulin bound iron results in part from the incorporation of the metal into hematopoietic foci, preparatory to hemoglobin synthesis, and deposition into the miscible iron pool.
To obviate this variation in combining capacity of different plasmas, a fairly pure source of beta-iglobulin was utilized to prepare the iron proteinate. The plasma fraction IV-7 (Cohn) as supplied is concentrated approximately 70-fold over normal plasma with respect to the metal combining globulin. When the radioiron is incubated with fraction IV-7 all radioiron disappearance rates are exponential irrespective of plasma iron concentration and the concentration and saturation of the circulating beta-1-globulin.
The nature of the radioiron disappearance curve deserves comment. Although no data for any period greater than six hours are available due to experimental limitations, it seems unlikely that any deviation from the exponential removal would occur. If this should happen, one would have to assume either an interruption of the steady state of the iron cycle or a feed-back of injected iron which has left the plasma. In the former instance, a new equilibrium would probably be reached and the function would again become exponential although possibly with a different rate constant. If feed-back is considered a possibility, this would imply a completion of the marrow or tissue store cycle which is highly improbable for the first few weeks, at least.
The rate ootdisappearance may be an average of several similar rates which are in turn dependent upon the uptake of iron by separate end organs, i.e., the erythropoietic tissue, the fixed iron stores and the available iron pool; or perhaps in a particular metabolic state, one rate, exponential in nature, so dominates the plasma iron turnover that other rates become insignificant. Thus, in marrow aplasia where only a few percent of an injected dose of radioactive iron ultimately appears in the red cells, the disappearance rate is influenced largely by the uptake of iron by the tissues; iron leaves the plasma at a very slow rate in the blood dyscrasias in which the production of red cells is grossly impaired, as in aplastic and aregenerative anemia (7) (8) (9) . On the other hand, in marrow hyperplasia, most of the radioiron becomes incorporated into the circulating erythrocytes (7) (8) (9) ; the rate of disappearance in this case is dependent in the main upon erythropoiesis, so that the presence-of greater than normal numbers of red cell precursors, such as are known to exist in the bone marrow of polycythemia vera, hemolytic anemia and iron deficiency anemia, is accompanied by a rapid clearance of iron. These findings suggest that the turnover of the plasma iron as measured by the radioactive technique is an index of the degree of erythropoiesis in the body.
In pernicious anemia in relapse, in view of the megaloblastic arrest of the marrow a decreased rate of plasma iron disappearance might be antici-pated. However, the values in two patients (cases 27 and 28) were quite rapid, 40 and 30 minutes, respectively. Six weeks following vitamin B12 therapy when the bone marrows were normal and the peripheral blood had returned nearly to normal, the study was repeated and respective rates of 90 and 55 minutes were obtained. In view of the high serum iron, complete saturation of the metal combining globulin and tissue hemosiderosis that exists in this disease, abnormal and rapid iron storage may play a role in the increased rate of plasma iron disappearance. Another possible explanation is the avidity of the marrow for iron in these cases because of actual increased erythropoiesis. The gross morphologic picture of red marrow replacing the normally yellow marrow areas coincides with this idea. It is possible that the erythrocytes and red cell precursors which are formed in pernicious anemia are broken down in situ. This is suggested by an excretion of urobilinogen far above that which would be derived from ordinary hemolysis in this disease. In this regard, London and West (10) have shown, using N15 labelled glycine in a case of pernicious anemia in relapse, that 40% of the urobilinogen appearing in the stool was not derived from circulating erythrocytes.
The bone marrow in myelofibrosis is hypocellular and a large portion of the marrow cavity is replaced by fibrous tissue or bone. There is usually a progressive splenomegaly with the spleen gradually assuming the erythropoietic function. Because of this compensatory metaplasia in the spleen, relatively good hemoglobin levels may be maintained for long periods of time. In view of the hypoplastic, fibrotic bone marrow, a slow rate of clearance of iron could be expected; however, most of the rates were rapid or within the normal range in the cases studied. This may be due to active red cell production in the spleen with, in some cases, a concomitant increased destruction of erythrocytes to account for the anemia. An elevation in the fecal and urinary urobilinogen was present in these latter cases and is suggestive confirmatory evidence of such a process. One of these patients (case 21) who had received a total of 650r to the spleen in a three week period, died subsequently. At autopsy the spleen showed very slight erythropoiesis contrary to that usually observed in myelofibrosis of advanced degree with myeloid metaplasia in the spleen. The prolongation of the half-time of disappearance of the plasma radioiron by splenic irradiation in the two patients mentioned above, demonstrates the effect of erythropoietic activity on plasma radioiron clearance. Furthermore, it emphasizes the importance of the spleen as a blood forming organ in this syndrome. The only patient of this group with a prolonged rate of disappearance was case 15, in whom there was a marked degree of exogenous hemochromatosis, secondary to multiple blood transfusions.
The influence of increased iron stores upon the rate of radioiron disappearance from the plasma is important. Data bearing on a closely allied problem have been reported by Finch and associates (7, 11) . They found that in patients with endogenous hemochromatosis, radioiron utilization is profoundly depressed while erythrocyte production proceeds normally. Similarly, in normal subjects fed large quantities of iron for fairly long periods, the utilization of iron is reduced. Again, in iron loading experiments in dogs, comparison of pre-and post-loading utilization curves showed a markedly decreased uptake in the latter. It appears fairly definite therefore that increased iron stores depress the utilization of radioiron for hemoglobin production. Increased iron stores may similarly affect the rate of disappearance of radioactive iron from the plasma. Our data are as yet too meager to resolve this question. As has been noted above, case 15 with myelofibrosis and hemosiderosis exhibited a markedly prolonged T%; however, another subject (case 18) with the same combined syndrome, who had received an even larger number of blood transfusions, had a normal iron disappearance rate. All the patients with aregenerative and aplastic anemia had hemosiderosis, but it appears more likely that the marrow aplasia rather than the enlarged iron depots is the primary factor in prolonging the disappearance rate in these cases.
Although it is possible that iron stores, may affect the radioiron disappearance rate, it has been demonstrated that marked variations in plasma iron clearance may occur in the same patient with no change in iron stores. Thus, the patient with polycythemia vera (case 26) who received 5 millicuries of P82 exhibited a pretreatment of T% of 30 minutes which then became prolonged to 145 minutes one month later. At the same time, the packed cell volume decreased from 51%o to 48%b and the per cent of erythroid elements in the sternal marrow similarly showed a reduction from 60%o to 25%o. The decrease in the half-time of disappearance was then a gauge of the effectiveness of bone marrow irradiation in depressing erythropoiesis. In view of the very slight decrease in hematocrit and no essential change in serum iron concentration (see Table I ), it is clear that no alteration in iron stores was likely.
As has been previously noted, two patients with myelofibrosis had received localized irradiation to the spleen immediately following which the radioiron disappearance rates decreased. No bleeding was observed nor were any transfusions administered in the interim. During this period, the packed cell volumes decreased moderately while the serum iron remained essentially unchanged. Here again in the presence of constant iron -stores a marked decrease occurred in the turnover of radioactive iron from the plasma.
It is apparent that the removal of radioiron from the plasma is an index of red cell production in the body inpatients with normal iron stores. A change in the steady state of the turnover of iron will produce an effect on the iron clearance from the plasma. Following the establishment of a new equilibrium, a new iron disappearance rate constant will be obtained. The rate of iron disappearance may be of value as a diagnostic test, particularly when combined with a study of the utilization of iron by the red cells. However, where large numbers of transfusions have been given, the rate of disappearance may be influenced by the increased fixed iron stores. The latter problem is currently being investigated in this laboratory. SUM MARY 1. A method for the determination of the rate of disappearance of iron from the plasma using radioactive iron and a solution of beta-l-globulin has been described.
2. A correlation between erythropoiesis and the rate of disappearance of radioiron from the plasma has been established.
3. In aplasia of the bone marrow, the rate of removal of radioiron from the plasma is markedly prolonged. Increased marrow erythropoiesis as occurs in polycythemia vera, hemolytic anemia and severe hypochromic anemia results in an increased rate of removal of radioiron from the plasma.
4. Greater than normal iron stores, as occurs in hemosiderosis, may prolong the plasma radioiron turnover.
5. It is suggested that with normal body iron stores the half-time of plasma radioiron disappearance is a sensitive measure of the integrity of the erythropoietic tissue of the body.
